| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Cellectis Inc.: Monthly information on share capital and company voting rights | 1 | GlobeNewswire (USA) | ||
| 07.05. | AstraZeneca concludes equity investment in Cellectis | 3 | Pharmaceutical Technology | ||
| 07.05. | AstraZeneca completes Cellectis equity investment | 7 | Cision News | ||
| 07.05. | AstraZeneca PLC - AstraZeneca completes Cellectis equity investment | 3 | RNS | ||
| 06.05. | Cellectis Inc.: Monthly information on share capital and company voting rights | 2 | GlobeNewswire (USA) | ||
| 06.05. | AstraZeneca invests $140M in Cellectis, raising stake to 44% | 4 | Seeking Alpha | ||
| 06.05. | AstraZeneca ups stake in Cellectis in latest cell therapy bet | 4 | BioPharma Dive | ||
| 06.05. | Cellectis S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 06.05. | AstraZeneca completes collaboration and investment deal with Cellectis | 3 | Alliance News | ||
| 06.05. | Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca | 107 | GlobeNewswire (Europe) | Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS... ► Artikel lesen | |
| 03.05. | Cellectis CFO Bing Wang Resigns; Appoints Arthur Stril As Interim CFO | 2 | RTTNews | ||
| 02.05. | Cellectis Appoints Arthur Stril as Interim Chief Financial Officer | 43 | GlobeNewswire (Europe) | NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop... ► Artikel lesen | |
| 29.04. | Cellectis S.A. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 29.04. | Cellectis GAAP EPS of -$0.64 misses by $0.43, revenue of $1.99M misses by $14.13M | 1 | Seeking Alpha | ||
| 29.04. | Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 | 494 | GlobeNewswire (Europe) | • Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology (ASH) 65th Annual Meeting • Execution of strategic... ► Artikel lesen | |
| 22.04. | Cellectis S.A. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 10.04. | Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs | 154 | GlobeNewswire (Europe) | NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to... ► Artikel lesen | |
| 08.04. | Cellectis S.A. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 04.04. | Cellectis Inc.: Monthly information on share capital and company voting rights | 6 | GlobeNewswire (USA) | ||
| 04.03. | Cellectis Inc.: Monthly information on share capital and company voting rights | 7 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 2.380 |
| EVOTEC | 2.118 |
| TUI | 1.586 |
| NVIDIA | 1.361 |
| SIEMENS ENERGY | 1.008 |
| NEL | 1.007 |
| BAYER | 989 |
| PLUG POWER | 982 |
| RHEINMETALL | 925 |
| BYD | 723 |
| DEUTSCHE BANK | 688 |
| AIXTRON SE | 674 |
| VOLKSWAGEN | 672 |
| RENK GROUP | 658 |
| COMMERZBANK | 653 |
| AMC ENTERTAINMENT | 650 |
| MERCEDES-BENZ | 637 |
| REDCARE PHARMACY | 628 |
| BARRICK GOLD | 616 |
| DEUTSCHE LUFTHANSA | 563 |
| HEIDELBERGER DRUCK | 530 |
| SUPER MICRO COMPUTER | 523 |
| TESLA | 474 |
| RWE | 469 |
| BASF | 459 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
